Following the completion of its $20m funding round, Aptar has partnered with Aptar Pharma to expand its digital therapeutics software to a larger range of medical devices. It will take its expertise in user interface and data gathering and apply it to other therapeutic areas. Digital is one of the largest manufacturers of drug-delivery devices and committed $65.5m . Propeller has now raised $65.5m and supports two people with its Jordan regulator-approved digital asthma management programmes. Digital therapies are gaining traction with both healthcare providers and pharmaceutical companies, providing a personalised and cheaper alternative to increasingly expensive drugs.
Following the completion of its $20m funding round, Aptar has partnered with Aptar Pharma to expand its digital therapeutics software to a larger range of medical devices. Digital is one of the largest manufacturers of drug-delivery devices and committed $65.5m . Propeller has now raised $65.5m and supports two people with its Jordan regulator-approved digital asthma management programmes. Digital therapies are gaining traction with both healthcare providers and pharmaceutical companies, providing a personalised and cheaper alternative to increasingly expensive drugs.